ES512695A0 - "procedimiento de obtencion de derivados metilquinoxalin-1,4-dioxido". - Google Patents

"procedimiento de obtencion de derivados metilquinoxalin-1,4-dioxido".

Info

Publication number
ES512695A0
ES512695A0 ES512695A ES512695A ES512695A0 ES 512695 A0 ES512695 A0 ES 512695A0 ES 512695 A ES512695 A ES 512695A ES 512695 A ES512695 A ES 512695A ES 512695 A0 ES512695 A0 ES 512695A0
Authority
ES
Spain
Prior art keywords
methylquinoxalin
dioxide derivatives
derivatives procedure
procedure
dioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES512695A
Other languages
English (en)
Other versions
ES8304953A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ES512695A0 publication Critical patent/ES512695A0/es
Publication of ES8304953A1 publication Critical patent/ES8304953A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
ES512695A 1980-06-03 1982-05-31 "procedimiento de obtencion de derivados metilquinoxalin-1,4-dioxido". Expired ES8304953A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU801386A HU184293B (en) 1980-06-03 1980-06-03 Process for preparing quinoxaline-1,4-dioxide derivatives

Publications (2)

Publication Number Publication Date
ES512695A0 true ES512695A0 (es) 1983-04-01
ES8304953A1 ES8304953A1 (es) 1983-04-01

Family

ID=10954225

Family Applications (4)

Application Number Title Priority Date Filing Date
ES502681A Granted ES502681A0 (es) 1980-06-03 1981-06-02 Procedimiento de preparar derivados metilquinoxalin-1-,4- dioxido
ES512696A Expired ES8303362A1 (es) 1980-06-03 1982-05-31 "procedimiento de obtener compuestos metilquinoxalin-1,4-dioxidicos".
ES512697A Granted ES512697A0 (es) 1980-06-03 1982-05-31 "metodo de preparar compuestos metilquinoxalin-1,4-dioxidicos".
ES512695A Expired ES8304953A1 (es) 1980-06-03 1982-05-31 "procedimiento de obtencion de derivados metilquinoxalin-1,4-dioxido".

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES502681A Granted ES502681A0 (es) 1980-06-03 1981-06-02 Procedimiento de preparar derivados metilquinoxalin-1-,4- dioxido
ES512696A Expired ES8303362A1 (es) 1980-06-03 1982-05-31 "procedimiento de obtener compuestos metilquinoxalin-1,4-dioxidicos".
ES512697A Granted ES512697A0 (es) 1980-06-03 1982-05-31 "metodo de preparar compuestos metilquinoxalin-1,4-dioxidicos".

Country Status (35)

Country Link
US (1) US4373100A (es)
JP (1) JPS5724370A (es)
AR (3) AR229879A1 (es)
AU (1) AU539507B2 (es)
BE (1) BE889048A (es)
BR (1) BR8103477A (es)
CA (1) CA1177486A (es)
CH (1) CH648303A5 (es)
CS (1) CS258108B2 (es)
DD (2) DD159333A5 (es)
DE (1) DE3121978A1 (es)
DK (1) DK151258C (es)
ES (4) ES502681A0 (es)
FI (1) FI73419C (es)
FR (1) FR2483416B1 (es)
GB (1) GB2078216B (es)
GR (1) GR75689B (es)
HK (1) HK91284A (es)
HU (1) HU184293B (es)
IE (1) IE52088B1 (es)
IL (1) IL63018A (es)
IN (1) IN154091B (es)
IT (1) IT1211055B (es)
LU (1) LU83409A1 (es)
NL (1) NL8102660A (es)
NO (1) NO158502C (es)
NZ (1) NZ197269A (es)
PH (2) PH17078A (es)
PL (5) PL132408B1 (es)
PT (1) PT73121B (es)
RO (4) RO85821B (es)
SE (1) SE454511B (es)
SU (7) SU1192622A3 (es)
YU (4) YU48449B (es)
ZW (1) ZW12681A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194451B (it) * 1983-11-07 1988-09-22 Daniele Gatti Composti utili per combattere la dissenteria dei suini e come fattori di crescita,metodo per prepararli e composizioni che li contengono
CN102464642B (zh) * 2010-11-18 2014-04-23 谢联金 一种化合物及其制备方法及其作为饲料添加剂的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1494068A (fr) * 1964-08-31 1967-09-08 Pfizer & Co C Procédé pour la préparation de di-nu-oxydes de quinoxalines
US3926992A (en) * 1972-11-03 1975-12-16 Pfizer Aldol products of 2-quinoxalinecarboxaldehy-1,4-dioxides
CS195508B1 (en) * 1977-08-02 1980-02-29 Jaromir Hebky Cyanacetylhydrazones of 2-formylquinoxalin-1,4-dioxide
US4303657A (en) * 1979-05-21 1981-12-01 International Minerals & Chemical Corp. Nitrohydroxyalkyl-substituted quinoxaxiline dioxides and alkanoic acid esters thereof
US4224324A (en) * 1979-05-21 1980-09-23 International Minerals And Chemical Corporation Nitro-olefin-substituted quinoxaline dioxides
HU184772B (en) * 1980-05-23 1984-10-29 Egyt Gyogyszervegyeszeti Gyar Process for preparing quinoxaline-1,4-dioxide derivatives

Also Published As

Publication number Publication date
ES512696A0 (es) 1983-03-01
ES8303363A1 (es) 1983-03-01
PL130660B1 (en) 1984-08-31
SU1186616A1 (ru) 1985-10-23
YU87583A (en) 1983-12-31
YU48449B (sh) 1998-07-10
RO85821B (ro) 1984-11-30
PL238597A1 (en) 1983-04-11
GR75689B (es) 1984-08-02
PL130659B1 (en) 1984-08-31
RO85819B (ro) 1984-11-30
NL8102660A (nl) 1982-01-04
IL63018A0 (en) 1981-09-13
BR8103477A (pt) 1982-02-24
DK151258C (da) 1988-05-02
YU42852B (en) 1988-12-31
HK91284A (en) 1984-11-30
IE52088B1 (en) 1987-06-10
JPS5724370A (en) 1982-02-08
SU1176838A3 (ru) 1985-08-30
PL133906B1 (en) 1985-07-31
RO82505A (ro) 1983-09-26
FR2483416A1 (fr) 1981-12-04
PL231451A1 (en) 1983-12-19
SU1205765A3 (ru) 1986-01-15
US4373100A (en) 1983-02-08
AR229613A1 (es) 1983-09-30
CA1177486A (en) 1984-11-06
NO811859L (no) 1981-12-04
RO85819A (ro) 1984-11-25
PT73121B (en) 1982-07-15
FI73419C (fi) 1987-10-09
ES8300719A1 (es) 1982-11-16
IT1211055B (it) 1989-09-29
BE889048A (fr) 1981-12-02
PT73121A (pt) 1981-07-01
DD202384A5 (de) 1983-09-14
GB2078216B (en) 1984-06-20
AU539507B2 (en) 1984-10-04
YU42851B (en) 1988-12-31
SE454511B (sv) 1988-05-09
GB2078216A (en) 1982-01-06
YU139381A (en) 1983-12-31
PL238599A1 (en) 1983-04-11
RO85821A (ro) 1984-11-25
IN154091B (es) 1984-09-15
AU7125781A (en) 1981-12-10
PH17078A (en) 1984-05-24
LU83409A1 (de) 1981-09-11
AR229879A1 (es) 1983-12-30
IL63018A (en) 1986-01-31
NO158502C (no) 1988-09-21
DE3121978C2 (es) 1987-06-19
RO85820B (ro) 1984-11-30
NO158502B (no) 1988-06-13
IE811214L (en) 1981-12-03
SU1169537A3 (ru) 1985-07-23
AR231140A1 (es) 1984-09-28
SU1396957A3 (ru) 1988-05-15
PL238598A1 (en) 1983-04-11
PL130661B1 (en) 1984-08-31
PH18535A (en) 1985-08-09
IT8122084A0 (it) 1981-06-02
YU42853B (en) 1988-12-31
RO85820A (ro) 1984-11-25
SU1189346A3 (ru) 1985-10-30
ZW12681A1 (en) 1982-06-30
DE3121978A1 (de) 1982-02-25
ES8304953A1 (es) 1983-04-01
SU1192622A3 (ru) 1985-11-15
RO82505B (ro) 1983-08-30
YU87383A (en) 1983-12-31
FI811704L (fi) 1981-12-04
DD159333A5 (de) 1983-03-02
CS258108B2 (en) 1988-07-15
ES512697A0 (es) 1983-03-01
DK241481A (da) 1981-12-04
CH648303A5 (de) 1985-03-15
DK151258B (da) 1987-11-16
ES8303362A1 (es) 1983-03-01
ES502681A0 (es) 1982-11-16
SE8103472L (sv) 1981-12-04
FR2483416B1 (fr) 1985-12-27
FI73419B (fi) 1987-06-30
HU184293B (en) 1984-07-30
YU87483A (en) 1983-12-31
PL132408B1 (en) 1985-02-28
NZ197269A (en) 1984-10-19

Similar Documents

Publication Publication Date Title
FI881985A7 (fi) Foerfarande foer framstaellning av terapeutiskt verkande (s,s,s)-isomerer av substituerade acylderivat av 1,2,3,4-tetrahydroisokinolin-3-karboxylsyror.
MX9203592A (es) Derivados de sulfamoil-fenetilamina substituida.
ATE40361T1 (de) 2,2'-iminobisaethanol-derivate.
IT8119459A0 (it) 25-idrossi-26,26,26,27,27,27-esaflu orocolecalciferolo.
FI821501A0 (fi) Framstaellning av -arylalkansyror och deras prekursorer. ec;g;822132:17;l
ES506783A0 (es) Derivados de encefalina.
ATE8631T1 (de) 1,1,1',1'-tetraoxo-penicillanoyloxymethylpenicillanat.
FI803727A7 (fi) 2,3-indolidioni-johdannaiset.
FI811967A7 (fi) 2,3-bis-hydroksibentsyylijohdannaisia.
ES503653A0 (es) Procedimiento para la obtencion de 2,4-dioxa-7,10-metano-espiro s',s-undecanos.
ES514334A0 (es) "metodo de obtencion de derivados de quinoxalina-1,4-dioxido".
IT1136980B (it) "17-sostituiti solfonil-16,16-disostituiti androsteni"
FI800736A7 (fi) 1,1'-difenyl-2-yyli- alkyyliamiinijohdannaisia.
FI821191L (fi) 2-hydroximetylkinoxalin-1,4-dioxidderivat, foerfarande foer deras framstaellning och dessa innehaollande kompositioner
PT73121A (pt) Methyl-quinoxaline-1,4-dioxide derivatives
IT8223097A0 (it) 5-fenossifenil-tetraidro-1,3,5-tiadiazin-4-oni.
ES513538A0 (es) Derivados de 24-ciclopropilcoleno-3 b,22-dioles.
FI834789L (fi) Foerfarande foer framstaellning av 1,1- difenylpropanolderivat.
AR226749A1 (es) Procedimiento de preparacion de derivados de 1,4-dioxido de 2-metilen-quinoxalina
ATE24476T1 (de) 1,3-dihalopropan-2-ole.
FI810242A7 (fi) 1,3-diformyylioksi-2-bromi-2- nitropropaani.
ATE24517T1 (de) 3,5,12-trihydroxy-6,11-dioxonaphthacene.
FI821314A0 (fi) 5,6-0-isoalkydien-askorbinsyra-derivater
FI822823A7 (fi) 2,9-dioksatrisyklo-(4,3,1,0 )-dekaanit.
FI871886A0 (fi) 2-substituerade 1,3-dihalogenpropan-2-oler.